Literature DB >> 25643011

Influence of lipopolysaccharide-binding protein on pulmonary inflammation in gram-negative pneumonia.

Michael A Taddonio1, Vladislav Dolgachev, Markus Bosmann, Peter A Ward, Grace Su, Stewart C Wang, Mark R Hemmila.   

Abstract

Lipopolysaccharide-binding protein (LBP) is upregulated as part of the acute-phase response. Lipopolysaccharide-binding protein has a known multifunctional role in potentiating the recognition, clearance, and killing of gram-negative bacteria. In a Klebsiella pneumonia model, we previously demonstrated that LBP gene-deficient mice (LBP-/-) mice experience increased mortality when compared with wild-type (Wt) mice (98% vs. 59%). We hypothesize that LBP is essential to bacterial clearance from the lung, and its absence leads to alteration of the pulmonary inflammatory response to pneumonia. Twelve- to 16-week-old female C57Bl/6 Wt mice and age-matched LBP-/- mice were administered 1 × 10(3) colony-forming units of Klebsiella pneumoniae by intratracheal injection. Animals were euthanized at 6, 12, 24, or 36 h after inoculation. Lung tissue and bronchoalveolar lavage samples were obtained. Lung homogenate samples were assayed to determine quantitative bacterial load per whole lung, proinflammatory cytokine concentrations, myeloperoxidase activity, and assessment of pulmonary leukocyte populations. In vitro production of inflammatory mediators were also assayed after LPS stimulation of peritoneal macrophages isolated from Wt, Toll-like receptor 4 (TLR4)-deficient, and LBP-/- mice. The LBP-/- mice demonstrated significantly elevated levels of bacteria in the lung at 24 and 36 h when compared with Wt controls. The average lung levels of proinflammatory cytokines interleukin-1β (IL-1β), IL-6, keratinocyte-derived chemokine, and macrophage-inflammatory protein-2 were greater in the LBP mice and remained elevated longer when compared with those in the Wt mice. Myeloperoxidase activity, an indicator of neutrophil content, was significantly increased at time 36 h in the LBP mice. After in vitro stimulation of peritoneal macrophages with LPS, production of IL-1β, IL-6, IL-10, keratinocyte-derived chemokine, and macrophage-inflammatory protein-1α were suppressed in LBP and TLR4-deficient mice compared with that in Wt. Absence of a functional LBP-/- gene results in diminished clearance of gram-negative bacteria from the pulmonary system. Failure to recognize and clear gram-negative bacteria via the LBP/TLR4 axis results in an initial delayed inflammatory response. This delay in LBP-/- mice is followed by excessive amplification and prolonged elevation of proinflammatory mediators and neutrophil sequestration within the lungs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25643011      PMCID: PMC4433570          DOI: 10.1097/SHK.0000000000000349

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  26 in total

1.  Central role of toll-like receptor 4 signaling and host defense in experimental pneumonia caused by Gram-negative bacteria.

Authors:  Jill R Schurr; Erana Young; Pat Byrne; Chad Steele; Judd E Shellito; Jay K Kolls
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Improved survival in mice given systemic gene therapy in a gram negative pneumonia model.

Authors:  Mark R Hemmila; Ming-Hui Fan; Jiyoun Kim; Jian M Sun; Lars Steinstraesser; Ke Q Gong; Saman Arbabi; Rebecca M Minter; Daniel G Remick; Grace L Su; Stewart C Wang
Journal:  J Trauma       Date:  2005-06

3.  Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14.

Authors:  D Le Roy; F Di Padova; R Tees; S Lengacher; R Landmann; M P Glauser; T Calandra; D Heumann
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

4.  TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia.

Authors:  Janet S Lee; Charles W Frevert; Gustavo Matute-Bello; Mark M Wurfel; Venus A Wong; Shu-Min Lin; John Ruzinski; Steve Mongovin; Richard B Goodman; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-07-15       Impact factor: 5.464

5.  Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27(p28) from macrophages.

Authors:  Markus Bosmann; Mikel D Haggadone; Mark R Hemmila; Firas S Zetoune; J Vidya Sarma; Peter A Ward
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

6.  Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection.

Authors:  R S Jack; X Fan; M Bernheiden; G Rune; M Ehlers; A Weber; G Kirsch; R Mentel; B Fürll; M Freudenberg; G Schmitz; F Stelter; C Schütt
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

7.  Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome.

Authors:  T R Martin; G D Rubenfeld; J T Ruzinski; R B Goodman; K P Steinberg; D J Leturcq; A M Moriarty; G Raghu; R P Baughman; L D Hudson
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

8.  Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge.

Authors:  Lei Sun; Ren-Feng Guo; Michael W Newstead; Theodore J Standiford; Demetrio R Macariola; Thomas P Shanley
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

9.  Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo.

Authors:  Sylvia Knapp; Sandrine Florquin; Douglas T Golenbock; Tom van der Poll
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

10.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

View more
  6 in total

1.  Protective Effect of 2-Hydroxymethyl Anthraquinone from Hedyotis diffusa Willd in Lipopolysaccharide-Induced Acute Lung Injury Mediated by TLR4-NF-κB Pathway.

Authors:  Jiani Tan; Liu Li; Wenjing Shi; Dongdong Sun; Changliang Xu; Yunjie Miao; Huisen Fan; Jianrong Liu; Haibo Cheng; Mianhua Wu; Weixing Shen
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

2.  Lipopolysaccharide-Binding Protein Downregulates Fractalkine through Activation of p38 MAPK and NF-κB.

Authors:  Xia Huang; Yi Zeng; Yujie Jiang; Yueqiu Qin; Weigui Luo; Shulin Xiang; Suren R Sooranna; Liao Pinhu
Journal:  Mediators Inflamm       Date:  2017-05-29       Impact factor: 4.711

3.  Modulation of Innate Immunity by G-CSF and Inflammatory Response by LBPK95A Improves the Outcome of Sepsis in a Rat Model.

Authors:  Haoshu Fang; Chuanfeng Hua; Stefanie Weiss; Anding Liu; Wenhui Cheng; Ralf Claus; Jürgen Rödel; Olaf Dirsch; Uta Dahmen
Journal:  J Immunol Res       Date:  2018-11-07       Impact factor: 4.818

4.  Matrine Attenuates COX-2 and ICAM-1 Expressions in Human Lung Epithelial Cells and Prevents Acute Lung Injury in LPS-Induced Mice.

Authors:  Chian-Jiun Liou; You-Rong Lai; Ya-Ling Chen; Yi-Hsien Chang; Zih-Ying Li; Wen-Chung Huang
Journal:  Mediators Inflamm       Date:  2016-01-05       Impact factor: 4.711

5.  Electroporation-mediated delivery of the FER gene in the resolution of trauma-related fatal pneumonia.

Authors:  V A Dolgachev; R Goldberg; M V Suresh; B Thomas; N Talarico; M R Hemmila; K Raghavendran; D Machado-Aranda
Journal:  Gene Ther       Date:  2016-07-22       Impact factor: 5.250

6.  Electroporation-mediated delivery of FER gene enhances innate immune response and improves survival in a murine model of pneumonia.

Authors:  Vladislav Dolgachev; Sreehari Panicker; Sanjay Balijepalli; Lane Kelly McCandless; Yue Yin; Samantha Swamy; M V Suresh; Matthew J Delano; Mark R Hemmila; Krishnan Raghavendran; David Machado-Aranda
Journal:  Gene Ther       Date:  2018-06-15       Impact factor: 5.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.